What does increasing regulatory oversight mean for the pharma supply chain?
The Network Effect
AUGUST 26, 2014
Due to more complex supply chains, policy makers worldwide are enforcing stricter regulations for manufacturing and logistics. In the years to come, the FDA expects domestic GMP inspections to decrease and more inspections in the foreign arena (FDA 2013) reflecting the trend towards more globalized supply chains.
Let's personalize your content